Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.

[1]  P Reichardt,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  S. Litière,et al.  Prognostic stratification using the nomogram sarculator and its impact on study results in a randomized controlled trial (RCT) for localized soft tissue sarcomas (STS): A secondary analysis of the EORTC-STBSG 62931. , 2018 .

[3]  S. Sleijfer,et al.  Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey. , 2018, The oncologist.

[4]  E. Wardelmann,et al.  Perioperative Management of Extremity Soft Tissue Sarcomas. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Terrier,et al.  Is dose de-escalation possible in sarcoma patients treated with enlarged limb sparing resection? , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  L. Mariani,et al.  Soft tissue sarcoma nomograms and their incorporation into practice , 2017, Cancer.

[7]  J. Blay,et al.  Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. , 2017, The Lancet. Oncology.

[8]  A. Gronchi,et al.  Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications , 2017, Therapeutic advances in medical oncology.

[9]  Anurag K. Singh,et al.  Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  L. White,et al.  Phase 2 study of preoperative image‐guided intensity‐modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma , 2013, Cancer.

[11]  D. Biau,et al.  Local recurrence of localized soft tissue sarcoma , 2012, Cancer.

[12]  J. Verweij,et al.  Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. , 2012, The Lancet. Oncology.

[13]  S. Singer,et al.  The enigma of myxofibrosarcoma of the extremity , 2012, Cancer.

[14]  L. Mariani,et al.  Myxofibrosarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution , 2011, Annals of Surgical Oncology.

[15]  Peter Wust,et al.  Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. , 2010, The Lancet. Oncology.

[16]  L. Mariani,et al.  Extremity Soft Tissue Sarcoma in a Series of Patients Treated at a Single Institution: Local Control Directly Impacts Survival , 2010, Annals of surgery.

[17]  L. White,et al.  Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma , 2009, Cancer.

[18]  F. Farrokhyar,et al.  A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma , 2008, Cancer.

[19]  A. Davis,et al.  Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  M. Ballo,et al.  Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy , 2003, Cancer.

[21]  Jonathan J. Lewis,et al.  Histopathologic Type: An Independent Prognostic Factor in Primary Soft Tissue Sarcoma of the Extremity? , 2003, Annals of Surgical Oncology.

[22]  B. Zee,et al.  Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Jonathan J. Lewis,et al.  Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Davis,et al.  Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial , 2002, The Lancet.

[25]  J W Oosterhuis,et al.  A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. , 2001, European journal of cancer.

[26]  R. Sylvester,et al.  Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data , 1997 .

[27]  D. Crowther.  Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data , 1997, The Lancet.

[28]  E. Casper,et al.  Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  L. Mariani,et al.  Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. , 2016, The Lancet. Oncology.

[30]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .

[31]  B. Yeap,et al.  Prognostic Factors and Outcomes of Patients with Myxofibrosarcoma , 2012, Annals of Surgical Oncology.

[32]  L. Mariani,et al.  Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  S. Steinberg,et al.  Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.